-
2022-502193-16-00
5
2023-11-14
Chronic lymphocytic leukemia, Multiple Myeloma and Non-Hodgkin Lymphom
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2024-517628-20-00
11
2023-10-24
hypertension
-
2022-502160-20-00
5
2023-10-02
Idiopathic Immune Complex Mediated Membranoproliferative Glomeruloneph
-
2022-502357-34-00
5
2023-09-27
Extensive Stage Small Cell Lung Cancer
-
2023-507171-22-00
9
2023-06-21
Untreated Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-507396-21-00
4
2023-03-16
transfusion-dependent α- or β-thalassemia or low-risk myelodysplastic
-
2022-501600-10-00
5
2023-02-07
Atrial fibrillation and Chronic Kidney Disease stage 5
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2024-515064-31-00
4
2022-12-01
Refractory / relapsed Hodgkin's lymphoma
-
2023-504484-16-00
9
2022-11-18
Multiple Myeloma (MM)
-
2023-509283-14-00
1
2022-04-25
Advanced non-small cell lung cancer
-
2024-518685-27-00
5
2022-03-22
acute/decompensated heart failure
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2023-504949-31-00
3
2021-12-01
Advanced or metastatic non-squamous non-small lung cancer (mNSCLC) wit
-
2024-512982-15-00
5
2021-06-28
BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian cancer, Metas
-
2024-515063-66-00
4
2021-03-30
Early stage classical Hodgkin Lymphoma (cHL) without bulky lesions and
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2023-506914-32-00
4
2020-05-05
Pan tumor
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2025-520809-12-00
10
2025-10-16
Diabetic Macular Edema
-
2024-519773-19-00
5
2025-07-31
Gastroesophageal Junction Adenocarcinoma
-
2024-518030-83-00
5
2025-06-05
Wet age-related macular degeneration (wAMD)